title: Acceleration of Bcr-Abl+ leukemia induced by deletion of JAK2.
authors.affiliation: Department of Biomedical Science, Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna, Austria.
authors.forename: E
authors.initials: E
authors.lastname: Grundschober
authors.affiliation: Department of Biomedical Science, Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna, Austria.
authors.forename: A
authors.initials: A
authors.lastname: Hoelbl-Kovacic
authors.affiliation: 1] Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA [2] Gerstner Sloan-Kettering Graduate School in Biomedical Sciences, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
authors.forename: N
authors.initials: N
authors.lastname: Bhagwat
authors.affiliation: Department of Biomedical Science, Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna (VUV), Vienna, Austria.
authors.forename: B
authors.initials: B
authors.lastname: Kovacic
authors.affiliation: Department of Biomedical Science, Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna, Austria.
authors.forename: R
authors.initials: R
authors.lastname: Scheicher
authors.affiliation: Center for Physiology and Pharmacology, Medical University of Vienna (MUV), Vienna, Austria.
authors.forename: E
authors.initials: E
authors.lastname: Eckelhart
authors.affiliation: Department of Biomedical Science, Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna, Austria.
authors.forename: K
authors.initials: K
authors.lastname: Kollmann
authors.affiliation: Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
authors.forename: M
authors.initials: M
authors.lastname: Keller
authors.affiliation: Ludwig Boltzmann Institute for Cancer Research (LBI-CR), Vienna, Austria.
authors.forename: F
authors.initials: F
authors.lastname: Grebien
authors.affiliation: Eppley Institute for Research in Cancer and Allied Diseases, 985950 Nebraska Medical Center, Omaha, NE, USA.
authors.forename: K U
authors.initials: KU
authors.lastname: Wagner
authors.affiliation: 1] Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA [2] Department of Medicine, Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
authors.forename: R L
authors.initials: RL
authors.lastname: Levine
authors.affiliation: Department of Biomedical Science, Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna, Austria.
authors.forename: V
authors.initials: V
authors.lastname: Sexl
mesh_terms: D000818:Animals; D016044:Fusion Proteins, bcr-abl / Q000032:analysis*; D006412:Hematopoietic Stem Cells / Q000502:physiology; D006801:Humans; D053614:Janus Kinase 2 / Q000037:antagonists & inhibitors / Q000502:physiology*; D007938:Leukemia / Q000209:etiology*; D051379:Mice
chemical_list: D016044:Fusion Proteins, bcr-abl; C507924:JAK2 protein, human; D053614:Janus Kinase 2